文献速递类风湿关节炎其他结缔组织病

类风湿关节炎相关间质性肺病与特发性肺纤维化的血清蛋白生物标志物比较分析

Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.
PubMed 文献 · Arthritis Rheumatol · 2020-02-05

本研究通过多重酶联免疫吸附试验(ELISA)检测45种血清蛋白生物标志物,比较类风湿关节炎相关间质性肺病(RA-ILD)、无ILD的RA患者、特发性肺纤维化(IPF)患者及健康对照。结果显示,RA-ILD与无ILD的RA患者间存在非重叠生物标志物,且IPF与RA-ILD的重叠模式在VA与非VA队列中不同,LASSO模型可区分RA-ILD与无ILD的RA。

要点

  • 多重ELISA可区分RA-ILD与无ILD的RA患者,生物标志物在调整模型中非重叠。
  • IPF与RA-ILD的血清蛋白重叠模式在VA与非VA队列间存在差异。
  • PCA显示VA队列中RA-ILD相关标志物涵盖促炎细胞因子/趋化因子及两个MMP亚群。

核心结论

  • 比较血清蛋白生物标志物分析是区分RA-ILD与无ILD的RA患者及识别与IPF共享的人群特异性介质的可行方法。

研究设计与样本

  • 使用多重ELISA分析45种血清蛋白生物标志物,包括细胞因子/趋化因子、生长因子和基质金属蛋白酶(MMP)。
  • 样本来自两个独立队列(VA和非VA)的RA-ILD患者、无ILD的RA患者、IPF患者及健康对照。
  • 采用调整线性回归、主成分分析(PCA)和LASSO建模比较亚组间血清蛋白水平。

主要发现

  • 在调整回归模型中,RA-ILD与无ILD的RA患者间存在多个非重叠的生物标志物。
  • IPF患者的判别性蛋白标志物面板(调整年龄/性别/吸烟)与RA-ILD的相关性在VA和非VA队列中显示不同重叠。
  • PCA显示VA队列中RA-ILD相关标志物包括促炎细胞因子/趋化因子和两个不同的MMP亚群。
  • LASSO回归在非VA和VA队列中识别出可区分RA-ILD与无ILD的RA患者的不同生物标志物组合。

临床怎么用

  • 血清蛋白生物标志物多重检测可能辅助区分RA-ILD与无ILD的RA患者。
  • 识别与IPF共享的人群特异性介质可能为理解RA-ILD与IPF的重叠提供线索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Interstitial lung disease (ILD) is a frequent complication of rheumatoid arthritis (RA), occurring in up to 40% of patients during the course of their disease. Early diagnosis is critical, particularly given the shared clinicoepidemiologic features between advanced rheumatoid arthritis-associated ILD (RA-ILD) and idiopathic pulmonary fibrosis (IPF). This study was undertaken to define the molecular basis of this overlap through comparative profiling of serum proteins in RA-ILD and IPF. METHODS: Multiplex enzyme-linked immunosorbent assays (ELISAs) were used to profile 45 protein biomarkers encompassing cytokines/chemokines, growth factors, and matrix metalloproteinases (MMPs) in sera obtained from RA patients with ILD and those without, individuals with IPF, and healthy controls. Levels of selected serum proteins were compared between patient subgroups using adjusted linear regression, principal component analysis (PCA), and least absolute shrinkage and selection operator (LASSO) modeling. RESULTS: Multiplex ELISA-based assessment of sera from 2 independent cohorts (Veterans Affairs [VA] and Non-VA) revealed a number of non-overlapping biomarkers distinguishing RA-ILD from RA without ILD (RA-no ILD) in adjusted regression models. Parallel analysis of sera from IPF patients also yielded a discriminatory panel of protein markers in models adjusted for age/sex/smoking, which showed differential overlap with profiles linked to RA-ILD in the VA cohort versus the Non-VA cohort. PCA revealed several distinct functional groups of RA-ILD-associated markers that, in the VA cohort, encompassed proinflammatory cytokines/chemokines as well as 2 different subsets of MMPs. Finally, LASSO regression modeling in the Non-VA and VA cohorts revealed distinct biomarker combinations capable of discriminating RA-ILD from RA-no ILD. CONCLUSION: Comparative serum protein biomarker profiling represents a viable method for distinguishing RA-ILD from RA-no ILD and identifying population-specific mediators shared with IPF.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Kass DJ, Nouraie M, Glassberg MK, et al. Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis. Arthritis Rheumatol. 2020. PMID: 31532072. doi:10.1002/art.41123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。